Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 1/2021

12.06.2020

Operator learning curve and clinical outcomes of zero fluoroscopy catheter ablation of atrial fibrillation, supraventricular tachycardia, and ventricular arrhythmias

verfasst von: Arshneel Kochar, Taha Ahmed, Eoin Donnellan, Oussama Wazni, Patrick Tchou, Roy Chung

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the learning curve for atrial fibrillation (AF), supraventricular tachycardia (SVT), and premature ventricular contraction (PVC) radiofrequency ablation (RFA) using zero fluoroscopy.

Methods

This is a retrospective, single-center study of 167 patients undergoing ablation between 2016 and 2019. Minimal fluoroscopy approach was initiated after the first 20 cases of PVI and SVT RFA. Procedures were divided consecutively into increments of 10 cases to determine operator learning curve.

Results

A total of 64 (38%) had SVT ablations, 26 (16%) had PVC ablations, and 77 (46%) had AF and underwent PVI. For SVT RFA, fluoroscopy time improved from 4.1 ± 3.5 min during the first 10 cases to 0.8 ± 1.2 min after 50 cases (p = 0.0001). Sixty-two out of 64 (97%) of cases were successful. In PVC RFA, fluoroscopy time was 7.7 ± 5.5 min for the first 5, 2.3 ± 3.4 min after 15, and 0 min after 20 cases (p = 0.0008). Twenty-four out of 26 (92%) of cases were acutely successful with recurrence in 2/26 (8%) of patients over 9 ± 9 months. In PVI, fluoroscopy time was 9.9 ± 3.3 min over the first 20 cases, 2.6 ± 2.3 min after 40 cases, and 0.1 min after 50 cases (p < 0.0001). PVI procedure time was 170 ± 34 min after 60 cases from 235 ± 41 min initially (p 0.001). Six out of 77 (8%) had AF recurrence at 12 months.

Conclusions

Zero fluoroscopy ablation for AF, SVT, and PVC can be safely achieved without increasing procedure time. The steepest learning curve occurs over the first 20, 15, and 40 cases for SVT, PVC, and PVI ablation respectively.
Literatur
1.
Zurück zum Zitat Chambers CE. Occupational health hazards in interventional cardiology: expected inherent risk or preventable personal liability? JACC Cardiovasc Interv. 2015;8:628–30.CrossRef Chambers CE. Occupational health hazards in interventional cardiology: expected inherent risk or preventable personal liability? JACC Cardiovasc Interv. 2015;8:628–30.CrossRef
2.
Zurück zum Zitat Klein LW, Tra Y, Garratt KN, Powell W, Lopez-Cruz G, Chambers C, et al. Occupational health hazards of interventional cardiologists in the current decade: results of the 2014 SCAI membership survey. Catheter Cardiovasc Interv. 2015 Nov;86(5):913–24.CrossRef Klein LW, Tra Y, Garratt KN, Powell W, Lopez-Cruz G, Chambers C, et al. Occupational health hazards of interventional cardiologists in the current decade: results of the 2014 SCAI membership survey. Catheter Cardiovasc Interv. 2015 Nov;86(5):913–24.CrossRef
3.
Zurück zum Zitat Buchanan GL, Chieffo A, Mehilli J, Mikhail GW, Mauri F, Presbitero P, et al. The occupational effects of interventional cardiology: results from the WIN for safety survey. Eurointervention. 2012;8(6):658–63.CrossRef Buchanan GL, Chieffo A, Mehilli J, Mikhail GW, Mauri F, Presbitero P, et al. The occupational effects of interventional cardiology: results from the WIN for safety survey. Eurointervention. 2012;8(6):658–63.CrossRef
4.
Zurück zum Zitat Yang L, Sun G, Chen X, Chen G, Yang S, Guo P, et al. Meta-analysis of zero or near-zero fluoroscopy use during ablation of cardiac arrhythmias. Am J Cardiol. 2016;118(10):1511–8.CrossRef Yang L, Sun G, Chen X, Chen G, Yang S, Guo P, et al. Meta-analysis of zero or near-zero fluoroscopy use during ablation of cardiac arrhythmias. Am J Cardiol. 2016;118(10):1511–8.CrossRef
5.
Zurück zum Zitat Razminia M, Willoughby MC, Demo H, Keshmiri H, Wang T, D’Silva OJ, et al. Fluoroless catheter ablation of cardiac arrhythmias: a 5 year experience. Pacing Clin Electrophyiol. 2017;40(4):425–33.CrossRef Razminia M, Willoughby MC, Demo H, Keshmiri H, Wang T, D’Silva OJ, et al. Fluoroless catheter ablation of cardiac arrhythmias: a 5 year experience. Pacing Clin Electrophyiol. 2017;40(4):425–33.CrossRef
6.
Zurück zum Zitat Lerman BB, Markowitz SM, Liu CF, Thomas G, Ip JE, Cheung JW. Fluoroless catheter ablation of atrial fibrillation. Heart Rhythm. 2017;14(6):928–34.CrossRef Lerman BB, Markowitz SM, Liu CF, Thomas G, Ip JE, Cheung JW. Fluoroless catheter ablation of atrial fibrillation. Heart Rhythm. 2017;14(6):928–34.CrossRef
7.
Zurück zum Zitat Bayanker T, Quadros KK, Thosani A, Yasmeh B, Mitra R, Liu E, et al. Safety and efficacy of zero fluoroscopy transseptal puncture with different approaches. Pacing Clin Electrophyiol. 2019;17. Bayanker T, Quadros KK, Thosani A, Yasmeh B, Mitra R, Liu E, et al. Safety and efficacy of zero fluoroscopy transseptal puncture with different approaches. Pacing Clin Electrophyiol. 2019;17.
8.
Zurück zum Zitat Sommer P, Bertagnoli L, Kircher S, Arya A, Bollmann A, Richter S, et al. Safety profile of near-zero fluoroscopy atrial fibrillation ablation with non-fluoroscopic catheter visualization: experience from 1000 consecutive procedures. Europace. 2018;20(12):1952–8.CrossRef Sommer P, Bertagnoli L, Kircher S, Arya A, Bollmann A, Richter S, et al. Safety profile of near-zero fluoroscopy atrial fibrillation ablation with non-fluoroscopic catheter visualization: experience from 1000 consecutive procedures. Europace. 2018;20(12):1952–8.CrossRef
9.
Zurück zum Zitat Santoro A, Di Clemente F, Baiocchi C, Zaca V, Bianchia C, Bellini C, et al. From near-zero to zero fluoroscopy catheter ablation procedures. J Cardiovasc Electrophysiol. 2019;30(11):2397–404.CrossRef Santoro A, Di Clemente F, Baiocchi C, Zaca V, Bianchia C, Bellini C, et al. From near-zero to zero fluoroscopy catheter ablation procedures. J Cardiovasc Electrophysiol. 2019;30(11):2397–404.CrossRef
10.
Zurück zum Zitat Zei P, Hunter TD, Gache LM, O’Riordan G, Baykaner T, Brodt CR. Low-fluoroscopy atrial fibrillation ablation with contact force and ultrasound technologies: a learning curve. Pragmat Obs Res. 2019;10:1–7.CrossRef Zei P, Hunter TD, Gache LM, O’Riordan G, Baykaner T, Brodt CR. Low-fluoroscopy atrial fibrillation ablation with contact force and ultrasound technologies: a learning curve. Pragmat Obs Res. 2019;10:1–7.CrossRef
11.
Zurück zum Zitat Gist K, Tigges C, Smith G, Clark J. Learning curve for zero-fluoroscopy catheter ablation of AVNRT: early versus late experience. Pacing Clin Electropysiol. 2011;34(3):264–8.CrossRef Gist K, Tigges C, Smith G, Clark J. Learning curve for zero-fluoroscopy catheter ablation of AVNRT: early versus late experience. Pacing Clin Electropysiol. 2011;34(3):264–8.CrossRef
12.
Zurück zum Zitat Giaccardi M, Del Rosso A, Guarnaccia V, Ballo P, Mascia G, Chiodi L, et al. Near-zero x-ray in arrhythmia ablation using a 3-dimensional electroanatomic mapping system: a multicenter experience. Heart Rhythm. 2016;13(1):150–6.CrossRef Giaccardi M, Del Rosso A, Guarnaccia V, Ballo P, Mascia G, Chiodi L, et al. Near-zero x-ray in arrhythmia ablation using a 3-dimensional electroanatomic mapping system: a multicenter experience. Heart Rhythm. 2016;13(1):150–6.CrossRef
Metadaten
Titel
Operator learning curve and clinical outcomes of zero fluoroscopy catheter ablation of atrial fibrillation, supraventricular tachycardia, and ventricular arrhythmias
verfasst von
Arshneel Kochar
Taha Ahmed
Eoin Donnellan
Oussama Wazni
Patrick Tchou
Roy Chung
Publikationsdatum
12.06.2020
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 1/2021
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-020-00798-8

Weitere Artikel der Ausgabe 1/2021

Journal of Interventional Cardiac Electrophysiology 1/2021 Zur Ausgabe

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

24.04.2024 ACC 2024 Nachrichten

Eine FFR-gesteuerte komplette Revaskularisation war in einer Studie bei Patienten mit akutem Myokardinfarkt und koronarer Mehrgefäßerkrankung klinisch nicht wirksamer als eine alleinige Revaskularisation der Infarktarterie.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.